Introduction: Jiangsu yabang Pharmaceutical Group has been acquired by yabang Chemical Group since 2002, including Changzhou No.3 Pharmaceutical Factory, Jiangsu Linhai Pharmaceutical Co., Ltd., Yancheng Epson Pharmaceutical Co., Ltd. and Yancheng Shengyuan Pharmaceutical Co., Ltd.; On the basis of establishing two medical research institutes in Nanjing and Changzhou, two pharmaceutical companies, such as Jintan Pharmaceutical Company and Xiangshui Pharmaceutical Company, were established. Since 2003, Anhui yabang Health Products Company, Changzhou yabang Pharmaceutical Co., Ltd., Changzhou yabang Wuzhou Pharmaceutical Co., Ltd. and Yancheng yabang Pharmaceutical Co., Ltd. have been established one after another. The registered capital of the Group and its subsidiaries is 290 million yuan, the total assets are 620 million yuan, and the employees are 1650, covering an area of 300,000 square meters. In 2004, the sales exceeded 500 million yuan, and the annual growth rate was 50%. Jiangsu yabang Pharmaceutical Group mainly produces and sells western medicine raw materials and hundreds of varieties of large-capacity injections, small-capacity injections, tablets, granules, capsules, oral liquids, eye drops, ointments, suspensions, syrups, etc. The business scope of pharmaceutical companies includes the purchase and sale of Chinese patent medicines, Chinese herbal medicines, Chinese herbal pieces, chemical pharmaceutical preparations, chemical raw materials, antibiotics, biochemical drugs and biological products (except vaccines), and the purchase and sale of first-and second-class medical devices, aerosol insecticides, ether, alcohol (medical use), turpentine, tinea potions, medicines and health products, sanitary materials, dressings and washing products. The pharmaceutical group has more than 30 senior professionals such as postdoctoral doctors and masters. Independent research and development of more than 20 kinds of new drugs every year is one of the pharmaceutical companies with the largest investment in new drug research and development and the largest variety of new drugs and generic drugs in China. Since 2002, the pharmaceutical group has invested more than 200 million yuan to rebuild all the acquired pharmaceutical factories and foreign companies, and all of them passed GMP and GSP certification by the end of 2004.
Legal Representative: Yang Jianze
Date of establishment: 2001-01-17.
Registered capital: 40 million yuan.
Location: Jiangsu Province
Unified social credit code: 91320921703859698e.
Operating conditions: In operation.
Industry: manufacturing industry
Company type: limited liability company (sole proprietorship)
English name: Jiangsu Epson Pharmaceutical Co., Ltd.
Staff size: 100-500 people.
Enterprise Address: Economic Development Zone, Xiangshui County, Yancheng City
Scope of business: production and sales of hard capsules, tablets, granules and eye drops; Self-management and agency of import and export of all kinds of goods and technologies (except those restricted or prohibited by the state). (Projects subject to approval according to law can only be operated after approval by relevant departments)